JP2023517312A5 - - Google Patents
Info
- Publication number
- JP2023517312A5 JP2023517312A5 JP2022553214A JP2022553214A JP2023517312A5 JP 2023517312 A5 JP2023517312 A5 JP 2023517312A5 JP 2022553214 A JP2022553214 A JP 2022553214A JP 2022553214 A JP2022553214 A JP 2022553214A JP 2023517312 A5 JP2023517312 A5 JP 2023517312A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- humans
- hiv infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985946P | 2020-03-06 | 2020-03-06 | |
| US62/985,946 | 2020-03-06 | ||
| PCT/IB2021/051765 WO2021176367A1 (en) | 2020-03-06 | 2021-03-03 | Inhibitors of human immunodeficiency virus replication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517312A JP2023517312A (ja) | 2023-04-25 |
| JP2023517312A5 true JP2023517312A5 (cg-RX-API-DMAC7.html) | 2024-03-13 |
Family
ID=74870854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022553214A Pending JP2023517312A (ja) | 2020-03-06 | 2021-03-03 | ヒト免疫不全ウイルスの複製阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12703699B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4114527A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023517312A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021176367A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA53973A (fr) | 2018-10-24 | 2022-02-09 | Viiv Healthcare Uk No 5 Ltd | Inhibiteurs de la réplication du virus de l'immunodéficience humaine |
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Viiv醫療保健英國(No 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| TW202448483A (zh) | 2023-05-31 | 2024-12-16 | 美商基利科學股份有限公司 | 用於hiv之治療性化合物 |
| AR132951A1 (es) | 2023-06-15 | 2025-08-13 | Viiv Healthcare Uk No 5 Ltd | Métodos e intermedios para preparar compuestos |
| WO2025169059A1 (en) | 2024-02-05 | 2025-08-14 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| CA2840095A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| EP2943493B1 (en) | 2013-01-09 | 2017-08-02 | Gilead Sciences, Inc. | Therapeutic compounds for the treatment of viral infections |
| US9220710B2 (en) | 2013-01-09 | 2015-12-29 | Gilead Sciences, Inc. | Therapeutic compounds |
| TWI694071B (zh) * | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| US10035760B2 (en) | 2013-10-24 | 2018-07-31 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| US9873680B2 (en) | 2014-08-29 | 2018-01-23 | Gilead Sciences, Inc. | Therapeutic compounds |
| US9855230B2 (en) | 2014-09-09 | 2018-01-02 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| TWI695003B (zh) * | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| PT3286166T (pt) | 2015-04-23 | 2020-08-18 | Viiv Healthcare Uk No 5 Ltd | Inibidores de replicação do vírus da imunodeficiência humana |
| AU2016250662A1 (en) | 2015-04-23 | 2017-11-16 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| LT3347352T (lt) | 2016-08-19 | 2019-08-12 | Gilead Sciences, Inc. | Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui |
| TW201906834A (zh) | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| TW202024061A (zh) | 2017-08-17 | 2020-07-01 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| AR112412A1 (es) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
| WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
| KR102847339B1 (ko) | 2018-02-16 | 2025-08-19 | 길리애드 사이언시즈, 인코포레이티드 | 레트로비리다에 바이러스 감염의 치료에 유용한 치료 화합물을 제조하기 위한 방법 및 중간체 |
| WO2019198024A1 (en) | 2018-04-11 | 2019-10-17 | VIIV Healthcare UK (No.5) Limited | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication |
| CA3108633A1 (en) | 2018-08-09 | 2020-02-13 | Viiv Healthcare Uk (No 5) Limited | Inhibitors of human immunodeficiency virus replication |
| WO2020058844A1 (en) | 2018-09-20 | 2020-03-26 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| ES2969030T3 (es) | 2018-10-29 | 2024-05-16 | Viiv Healthcare Uk No 5 Ltd | Derivados de quinazolinil-indazol y su uso como inhibidores de replicación de virus de inmunodeficiencia humana |
| JP2022506399A (ja) | 2018-11-05 | 2022-01-17 | ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| US20210395248A1 (en) | 2018-11-05 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| UY38559A (es) | 2019-02-01 | 2020-07-31 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicación del virus de la inmunodeficiencia humana |
| EP3986561B1 (en) | 2019-06-19 | 2024-02-14 | VIIV Healthcare UK (No.5) Limited | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication |
| IL293566A (en) | 2019-12-09 | 2022-08-01 | Viiv Healthcare Co | Pharmaceutical preparations containing Cabotgravir |
| WO2021176366A1 (en) | 2020-03-06 | 2021-09-10 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| EP4135702B1 (en) | 2020-04-15 | 2026-06-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
-
2021
- 2021-03-03 US US17/801,410 patent/US12703699B2/en active Active
- 2021-03-03 EP EP21711369.5A patent/EP4114527A1/en not_active Withdrawn
- 2021-03-03 WO PCT/IB2021/051765 patent/WO2021176367A1/en not_active Ceased
- 2021-03-03 JP JP2022553214A patent/JP2023517312A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102828456B1 (ko) | 벤조피라졸 화합물 및 이의 유사체 | |
| FI83312C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 7-(1-pyrrolidinyl)-1-cyklopropyl-6,8-difluor-1,4 -dihydro-4-oxo-3-kinolinkarboxylsyror och deras salter. | |
| JP4523281B2 (ja) | Hivインテグラーゼ阻害薬として有用なヒドロキシナフチリジノンカルボキサミド類 | |
| CN108727378A (zh) | 新型异喹啉类化合物及其医药用途 | |
| CN117715906A (zh) | 胰高血糖素样肽-1受体调节剂及其用途 | |
| JP2023517043A5 (cg-RX-API-DMAC7.html) | ||
| CN110461858A (zh) | 酰基核苷膦酸酯、其前药及其作为药物的用途 | |
| JP2022552156A5 (cg-RX-API-DMAC7.html) | ||
| EP3962603A1 (en) | Inhibitors of human immunodeficiency virus replication | |
| JP2022551256A5 (cg-RX-API-DMAC7.html) | ||
| JP2024528962A (ja) | シアノピリジンおよびシアノピリミジンbcl6分解剤 | |
| JP2025515833A5 (cg-RX-API-DMAC7.html) | ||
| US20030119848A1 (en) | Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient | |
| JP7618642B2 (ja) | インターロイキンの調節におけるプロドラッグ | |
| IL296902A (en) | n-Heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl)acetamide derivatives as sstr4 agonists | |
| JP2025538197A (ja) | Aak1阻害剤を含有する医薬組成物 | |
| JP2025518533A (ja) | インテグリン阻害剤の安定化 | |
| CN1183778A (zh) | 喹啉羧酸衍生物 | |
| JP7836529B2 (ja) | 腸内分解性共薬、その調製及び使用 | |
| JP2006512364A5 (cg-RX-API-DMAC7.html) | ||
| CN111936488B (zh) | 用于治疗寄生虫感染的新颖化合物 | |
| CN111087409B (zh) | 一种喹诺酮类化合物及其制备方法和应用 | |
| JP7446424B2 (ja) | スルホニル尿素環置換単環式β-ラクタム系抗生物質 | |
| JP3718262B2 (ja) | ホスフィン酸誘導体、その調製方法およびその使用 | |
| CN113082023B (zh) | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 |